Literature DB >> 12466498

Thermostability of mouse-passaged BSE and scrapie is independent of host PrP genotype: implications for the nature of the causal agents.

David M Taylor1, Karen Fernie1, Philip J Steele1, Irene McConnell1, Robert A Somerville1.   

Abstract

Five experimentally maintained strains of scrapie and BSE agents have been passaged in two PrP genotypes of mice. Brain macerates were autoclaved at 126 degrees C and the levels of surviving infectivity were measured by titration. There was a large difference in the survival properties of transmissible spongiform encephalopathy (TSE) infectivity between TSE strains. PrP genotype had little effect. Phenotypic properties of the TSE strains were not affected with the exception that with one strain (ME7), incubation periods of the heated sample were longer than the controls given equivalent doses. It is concluded that PrP is probably not responsible for differences in thermostability between strains. More likely, a host-independent molecule which differs in covalent structure between strains accounts for these properties.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12466498     DOI: 10.1099/0022-1317-83-12-3199

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Inactivation of prions by acidic sodium dodecyl sulfate.

Authors:  David Peretz; Surachai Supattapone; Kurt Giles; Julie Vergara; Yevgeniy Freyman; Pierre Lessard; Jiri G Safar; David V Glidden; Charles McCulloch; Hoang-Oanh B Nguyen; Michael Scott; Stephen J Dearmond; Stanley B Prusiner
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

2.  Strain-specified characteristics of mouse synthetic prions.

Authors:  Giuseppe Legname; Hoang-Oanh B Nguyen; Ilia V Baskakov; Fred E Cohen; Stephen J Dearmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-25       Impact factor: 11.205

3.  A Heparin Purification Process Removes Spiked Transmissible Spongiform Encephalopathy Agent.

Authors:  Cyrus Bett; Ksenija Grgac; Dianna Long; Michael Karfunkle; David A Keire; David M Asher; Luisa Gregori
Journal:  AAPS J       Date:  2017-01-23       Impact factor: 4.009

4.  Disease-associated prion protein elicits immunoglobulin M responses in vivo.

Authors:  Mourad Tayebi; Perry Enever; Zahid Sattar; John Collinge; Simon Hawke
Journal:  Mol Med       Date:  2004 Jul-Dec       Impact factor: 6.354

Review 5.  Environmental and host factors that contribute to prion strain evolution.

Authors:  Jason C Bartz
Journal:  Acta Neuropathol       Date:  2021-04-25       Impact factor: 17.088

6.  Stability of BSE infectivity towards heat treatment even after proteolytic removal of prion protein.

Authors:  Jan P M Langeveld; Anne Balkema-Buschmann; Dieter Becher; Achim Thomzig; Romolo Nonno; Olivier Andréoletti; Aart Davidse; Michele A Di Bari; Laura Pirisinu; Umberto Agrimi; Martin H Groschup; Michael Beekes; Jason Shih
Journal:  Vet Res       Date:  2021-04-16       Impact factor: 3.683

7.  Resistance of bovine spongiform encephalopathy (BSE) prions to inactivation.

Authors:  Kurt Giles; David V Glidden; Robyn Beckwith; Rose Seoanes; David Peretz; Stephen J DeArmond; Stanley B Prusiner
Journal:  PLoS Pathog       Date:  2008-11-14       Impact factor: 6.823

8.  Investigating the conformational stability of prion strains through a kinetic replication model.

Authors:  Mattia Zampieri; Giuseppe Legname; Claudio Altafini
Journal:  PLoS Comput Biol       Date:  2009-07-03       Impact factor: 4.475

9.  Differential expression of interferon responsive genes in rodent models of transmissible spongiform encephalopathy disease.

Authors:  Michael J Stobart; Debra Parchaliuk; Sharon L R Simon; Jillian Lemaistre; Jozef Lazar; Richard Rubenstein; J David Knox
Journal:  Mol Neurodegener       Date:  2007-03-16       Impact factor: 14.195

10.  Thermostability as a highly dependent prion strain feature.

Authors:  Alba Marín-Moreno; Patricia Aguilar-Calvo; Mohammed Moudjou; Juan Carlos Espinosa; Vincent Béringue; Juan María Torres
Journal:  Sci Rep       Date:  2019-08-06       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.